IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection

Journal of Immunology

Volumn 172, Issue 12, 2004, Pages 7603-7609

  Van Der Sluijs, Koenraad F ^a   Van Elden, Leontine J R ^b   Nijhuis, Monique ^b   Schuurman, Rob ^b   Pater, Jennie M ^a   Florquin, Sandrine ^a   Goldman, Michel ^c   Jansen, Henk M ^a   Lutter, René ^a   Van Der Poll, Tom ^a,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ERASME HOSPITAL   (Belgium)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXPERIMENTAL INFECTION; HISTOPATHOLOGY; HOST RESISTANCE; INFLUENZA; INFLUENZA VIRUS; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTION; VIRUS DETECTION; VIRUS INFECTION;

EID: 2942625718     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.12.7603     Document Type: Article

References (36)

1. Treanor, J. J. 2000. Orthomyxoviridae: influenza virus. In Principles and Practice of Infectious Diseases, 5th Ed. G. L. Mandell, D. R. Douglas, J. E Bennett, and R. Dolin, eds. Churchill Livingston, New York, pp. 1834-1835
2. Murphy, B. R., and R. G. Webster. 1996 Orthomyxoviruses. In Fields Virology, 3rd Ed. B. N. Fields, D. M. Knipe, and P. M. Howley, eds. Lippincott-Raven, Philadelphia, p. 1407.
3. Louria, D., H. Blumenfeld, J. Ellis, E. D. Kilbourne, and D. Rogers. 1959. Studies on influenza in the pandemic of 1957-58. II. Pulmonary complications of influenza. J. Clin. Invest. 38:213.
4. Simonsen, L., M. J. Carke, G. D. Williamson, D. F. Stroup, N. H. Arden, and L. B. Schonberger. 1997. The impact of influenza epidemics on mortality: introducing a severity index. Am. J. Public Health 87:1944.
5. O'Brien, K. L., M. I. Walters, J. Sellman, P. Quinlisk, H. Regnery, B. Schwartz, and S. F. Dowell. 2000. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin. Infect. Dis. 30:784.
6. Tashiro, M., P. Ciborowski, H.-D. Klenk, G. Pulverer, and R. Rott. 1987. Role of staphylococcus protease in the development of influenza pneumonia. Nature 325:536.
7. Jakab, G. J. 1985. Mechanisms of bacterial superinfection in viral pneumonias. Schweiz. Med. Wschr. 115:75.
8. Plotkowski, M.-C., E. Puchelle, G. Beck, J. Jacquot, and C. Hannoun. 1986. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. Am. Rev. Respir. Dis. 134:1040.
9. McCullers, J. A., and J. E. Rehg. 2002. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J. Infect. Dis. 186:341.
10. Zhang, W. J., S. Sarawar, P. Nguyen, K. Daly, J. E. Rehg, P. C. Doherty, D. L. Woodland, and M. A. Blackman. 1996. Lethal synergism between influenza and staphylococcal enterotoxin B in mice. J. Immunol. 157:5049.
11. Le Vine, A. M., V. Koenigsknecht, and J. M. Stark. 2001. Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice. J. Virol. Methods. 94:173.
12. Schultz, M. J., S. Knapp, and T. van der Poll. 2002. Regulatory role of alveolar macrophages and cytokines in pulmonary host defense. In: Yearbook of Intensive Care and Emergency Medicine. J. L. Vincent, eds. Springer-Verlag, Berlin, p. 65
13. Strieter, R. M., J. A. Belperio, and M. P. Keane. 2003. Host innate defenses in the lung: the role of cytokines. Curr. Opin. Infect. Dis. 16:193.
14. van der Poll, T., A. Marchant, C. V. Keogh, M. Goldman, and S. F. Lowry. 1996. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J. Infect. Dis. 174:994.
15. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:s493.
16. Lauw, F. N., J. Branger, S. Florquin, P. Speelman, S. J. van Deventer, S. Akira, and T. van der Poll. 2002. IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. J. Immunol. 168:372.
17. Rijneveld, A. W., S. Florquin, J. Branger, P. Speelman, S. J. van Deventer, and T. van der Poll. 2001. TNF-α compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia. J. Immunol. 167:5240.
18. Jovasevic, V. M., L. Gorelik, J. A. Bluestone, and M. B. Mokyr, 2004. Importance of IL-10 for CTLA-4-mediated inhibition of tumor-eradicating immunity. J. Immunol. 172:1449.
19. van der Poll, T., A. Marchant, W. A. Buurman, L. Berman, C. V. Keogh, D. D. Lazarus, L. Nguyen, M. Goldman, L. L. Moldawer, and S. F. Lowry. 1995. Endogenous IL-10 protects mice from death during septic peritonitis. J. Immunol. 155:5397.
20. Marchant, A., C. Bruyns, P. Vandenabeele, M. Ducarme, C. Gerard, A. Delvaux, D. De Groote, D. Abramowicz, T. Velu, and M. Goldman. 1994. Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia. Eur. J. Immunol. 24:1167.
21. Van Elden, L. J. R., M. Nijhuis, P. Schipper, R. Schuurman, and A. M. van Loon, 2001. Simultaneous detection of influenza virus A and B using real-time quantitative PCR. J. Clin. Microbiol. 39:196.
22. Knapp, S., J. C. Leemans, S. Florquin, J. Branger, N. A. Maris, J. Pater, N. van Rooijen, and T. van der Poll. 2003. Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. Am. J. Respir. Crit. Care Med. 167:171.
23. Kozak, W., V. Poli, D. Soszynski, C. A. Conn, L. R. Leon, and M. J. Kluger. 1997. Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis. Am. J. Physiol. 272:R621.
24. Jones, W. T., and J. H. Menna. 1982. Influenza type A virus-mediated adherence of type 1a group B streptococci to mouse tracheal tissue in vivo. Infect. Immun. 38:791.
25. Nugent, K. M., and E. L. Pesanti. 1983. Tracheal function during influenza infections. Infect. Immun. 42:1102.
26. Abramson, J. S., J. W. Parce, J. C. Lewis, D. S. Lyles, E. L. Mills, R. D. Nelson, and D. A. Bass. 1984. Characterization of the effect of influenza virus on polymorphonuclear leukocyte membrane responses. Blood 64:131.
27. Abramson, J. S., D. S. Lyles, K. A. Heller, and D. A. Bass. 1982. Depression of monocyte and polymorphonuclear leukocyte oxidative metabolism and bactericidal capacity by influenza A. Infect. Immun. 35:350.
28. Martin, R. R., R. B. Couch, S. B. Greenberg, T. R. Cate, and G. A. Warr. 1981. Effects of infection with influenza virus on the function of polymorphonuclear leukocytes. J. Infect. Dis. 135:645.
29. Jones, W. T., J. H. Menna, and D. E. Wennerstrom. 1983. Lethal synergism induced in mice by influenza type A virus and type Ia group B streptococci. Infect. Immun. 41:618.
30. Dallaire, F., N. Ouellet, Y. Bergeron, V. Turmel, M. C. Gauthier, M. Simard, and M. G. Bergeron. 2001. Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia. J. Infect. Dis. 184:292.
31. Opal, S. M., J. C. Wherry, and P. Grint. 1998. Interleukin-10: potential benefits and possible risks in clinical infectious diseases. Clin. Infect. Dis. 27:1497.
32. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683.
33. Pajkrt, D., L. Camoglio, M. C. Tiel-van Buul, K. de Bruin, D. L. Cutler, M. B. Affrime, G. Rikken, T. van der Poll, J. W. ten Cate, and S. J. van Deventer. 1997. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. J. Immunol. 158:3971.
34. Greenberger, M. J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, R. E. Goodman, and T. J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol. 155:722.
35. Steinhauser, M. L., C. M. Hogaboam, S. L. Kunkel, N. W. Lukacs, R. M. Strieter, and T. J. Standiford. 1999. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J. Immunol. 162:392.
36. Wagner, R. D., N. M. Maroushek, J. F. Brown, and C. J. Czuprynski. 1994. Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice. Infect. Immun. 62:2345.